• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医护人员中 SARS-CoV-2 抗体的血清流行率:一项横断面研究。

Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study.

机构信息

Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.

出版信息

BMJ Open. 2021 Feb 12;11(2):e043584. doi: 10.1136/bmjopen-2020-043584.

DOI:10.1136/bmjopen-2020-043584
PMID:33579769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7883610/
Abstract

OBJECTIVE

We sought to determine the extent of SARS-CoV-2 seroprevalence and the factors associated with seroprevalence across a diverse cohort of healthcare workers.

DESIGN

Observational cohort study of healthcare workers, including SARS-CoV-2 serology testing and participant questionnaires.

SETTINGS

A multisite healthcare delivery system located in Los Angeles County.

PARTICIPANTS

A diverse and unselected population of adults (n=6062) employed in a multisite healthcare delivery system located in Los Angeles County, including individuals with direct patient contact and others with non-patient-oriented work functions.

MAIN OUTCOMES

Using Bayesian and multivariate analyses, we estimated seroprevalence and factors associated with seropositivity and antibody levels, including pre-existing demographic and clinical characteristics; potential COVID-19 illness-related exposures; and symptoms consistent with COVID-19 infection.

RESULTS

We observed a seroprevalence rate of 4.1%, with anosmia as the most prominently associated self-reported symptom (OR 11.04, p<0.001) in addition to fever (OR 2.02, p=0.002) and myalgias (OR 1.65, p=0.035). After adjusting for potential confounders, seroprevalence was also associated with Hispanic ethnicity (OR 1.98, p=0.001) and African-American race (OR 2.02, p=0.027) as well as contact with a COVID-19-diagnosed individual in the household (OR 5.73, p<0.001) or clinical work setting (OR 1.76, p=0.002). Importantly, African-American race and Hispanic ethnicity were associated with antibody positivity even after adjusting for personal COVID-19 diagnosis status, suggesting the contribution of unmeasured structural or societal factors.

CONCLUSION AND RELEVANCE

The demographic factors associated with SARS-CoV-2 seroprevalence among our healthcare workers underscore the importance of exposure sources beyond the workplace. The size and diversity of our study population, combined with robust survey and modelling techniques, provide a vibrant picture of the demographic factors, exposures and symptoms that can identify individuals with susceptibility as well as potential to mount an immune response to COVID-19.

摘要

目的

我们旨在确定 SARS-CoV-2 血清流行率的程度,以及与不同人群的医护人员血清流行率相关的因素。

设计

对医护人员进行观察性队列研究,包括 SARS-CoV-2 血清学检测和参与者问卷调查。

地点

位于洛杉矶县的多站点医疗服务系统。

参与者

在位于洛杉矶县的多站点医疗服务系统中工作的成年人(n=6062),包括有直接病人接触的人和其他非面向病人的工作职能的人,人群多样且未进行选择。

主要结果

我们使用贝叶斯和多变量分析,估计了血清流行率和与血清阳性率及抗体水平相关的因素,包括预先存在的人口统计学和临床特征;与 COVID-19 相关的潜在疾病暴露;以及与 COVID-19 感染一致的症状。

结果

我们观察到血清流行率为 4.1%,嗅觉丧失是最突出的自我报告症状(OR 11.04,p<0.001),此外还有发热(OR 2.02,p=0.002)和肌痛(OR 1.65,p=0.035)。在调整潜在混杂因素后,血清流行率还与西班牙裔(OR 1.98,p=0.001)和非裔美国人(OR 2.02,p=0.027)种族以及与家中 COVID-19 确诊患者(OR 5.73,p<0.001)或临床工作环境(OR 1.76,p=0.002)接触有关。重要的是,非裔美国人种族和西班牙裔与抗体阳性有关,即使在调整个人 COVID-19 诊断状态后也是如此,这表明存在未测量的结构性或社会因素的影响。

结论和相关性

我们医护人员中与 SARS-CoV-2 血清流行率相关的人口统计学因素强调了工作场所以外的暴露源的重要性。我们的研究人群规模大且多样化,结合了强大的调查和建模技术,生动地描绘了人口统计学因素、暴露和症状,可以识别易感性高的个体以及对 COVID-19 产生免疫反应的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aff/7883610/9f772b5f3114/bmjopen-2020-043584f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aff/7883610/8eeaa9903ed6/bmjopen-2020-043584f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aff/7883610/d1572f9df5d9/bmjopen-2020-043584f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aff/7883610/62a1494e1a6b/bmjopen-2020-043584f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aff/7883610/13f0f48d99d6/bmjopen-2020-043584f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aff/7883610/9f772b5f3114/bmjopen-2020-043584f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aff/7883610/8eeaa9903ed6/bmjopen-2020-043584f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aff/7883610/d1572f9df5d9/bmjopen-2020-043584f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aff/7883610/62a1494e1a6b/bmjopen-2020-043584f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aff/7883610/13f0f48d99d6/bmjopen-2020-043584f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aff/7883610/9f772b5f3114/bmjopen-2020-043584f05.jpg

相似文献

1
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study.医护人员中 SARS-CoV-2 抗体的血清流行率:一项横断面研究。
BMJ Open. 2021 Feb 12;11(2):e043584. doi: 10.1136/bmjopen-2020-043584.
2
Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.医护人员中 SARS-CoV-2 抗体的血清流行率及相关因素:系统评价和荟萃分析。
J Hosp Infect. 2021 Feb;108:120-134. doi: 10.1016/j.jhin.2020.11.008. Epub 2020 Nov 16.
3
SARS-CoV-2 seroprevalence in healthcare workers in a tertiary healthcare network in Victoria, Australia.澳大利亚维多利亚州一个三级保健网络中卫生保健工作者的 SARS-CoV-2 血清流行率。
Infect Dis Health. 2021 Aug;26(3):208-213. doi: 10.1016/j.idh.2021.03.004. Epub 2021 Apr 13.
4
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study.SARS-CoV-2 血清流行率和医护人员无症状病毒携带情况:一项横断面研究。
Thorax. 2020 Dec;75(12):1089-1094. doi: 10.1136/thoraxjnl-2020-215414. Epub 2020 Sep 11.
5
The seroprevalence of SARS-CoV-2 in a rural southwest community.农村西南社区 SARS-CoV-2 的血清阳性率。
J Osteopath Med. 2021 Feb 1;121(2):199-210. doi: 10.1515/jom-2020-0287.
6
SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.SARS-CoV-2 抗体检测在医护人员中的应用:三种市售抗体检测试剂盒的临床性能比较。
Microbiol Spectr. 2021 Oct 31;9(2):e0039121. doi: 10.1128/Spectrum.00391-21. Epub 2021 Sep 29.
7
Cross-sectional study evaluating the seroprevalence of SARS-CoV-2 antibodies among healthcare workers and factors associated with exposure during the first wave of the COVID-19 pandemic in New York.横断面研究评估了 COVID-19 大流行第一波期间纽约医护人员中 SARS-CoV-2 抗体的血清阳性率,以及与暴露相关的因素。
BMJ Open. 2021 Nov 3;11(11):e053158. doi: 10.1136/bmjopen-2021-053158.
8
Disparities in Seroprevalence of SARS-CoV-2 Immunoglobulin Antibodies in a Large Midwestern Health Care System.在一个中西部大型医疗保健系统中,SARS-CoV-2 免疫球蛋白抗体的血清阳性率存在差异。
Public Health Rep. 2021 May;136(3):361-367. doi: 10.1177/0033354921999168. Epub 2021 Mar 5.
9
SARS-CoV-2 seroprevalence in healthcare workers of a teaching hospital in a highly endemic region in the Netherlands after the first wave: a cross-sectional study.荷兰高度流行地区一所教学医院的医护人员在第一波疫情后感染 SARS-CoV-2 的血清流行率:一项横断面研究。
BMJ Open. 2021 Oct 18;11(10):e051573. doi: 10.1136/bmjopen-2021-051573.
10
SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.危地马拉一家大容积眼科中心医护人员中 SARS-CoV-2 的血清流行率。
Ann Med. 2021 Dec;53(1):1956-1959. doi: 10.1080/07853890.2021.1993325.

引用本文的文献

1
Sex differences in adenosine deaminase activity associate with disparities in SARS-CoV-2 innate immunity.腺苷脱氨酶活性的性别差异与新冠病毒固有免疫的差异相关。
iScience. 2025 Apr 14;28(5):112418. doi: 10.1016/j.isci.2025.112418. eCollection 2025 May 16.
2
Prevalence of COVID-19 and associated factors among healthcare workers in the war-torn Tigray, Ethiopia.新冠疫情在饱受战争蹂躏的提格雷地区医护人员中的流行情况及相关因素。
PLoS One. 2024 Nov 21;19(11):e0310128. doi: 10.1371/journal.pone.0310128. eCollection 2024.
3
A multi-site cross-sectional study on the burden of SARS-CoV-2 in healthcare workers in Madagascar.

本文引用的文献

1
Stan: A Probabilistic Programming Language.斯坦:一种概率编程语言。
J Stat Softw. 2017;76. doi: 10.18637/jss.v076.i01. Epub 2017 Jan 11.
2
Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗体血清阳性率的贝叶斯估计。
JAMIA Open. 2020 Nov 23;3(4):496-499. doi: 10.1093/jamiaopen/ooaa049. eCollection 2020 Dec.
3
A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population.
马达加斯加医护人员中 SARS-CoV-2 负担的多地点横断面研究。
PLoS One. 2024 Oct 24;19(10):e0309977. doi: 10.1371/journal.pone.0309977. eCollection 2024.
4
Sources of exposure and risk among employees infected with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in a large, urban, tertiary-care hospital in the United States.美国一家大型城市三级护理医院中感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的员工的暴露源和风险
Antimicrob Steward Healthc Epidemiol. 2023 Jan 30;3(1):e20. doi: 10.1017/ash.2022.366. eCollection 2023.
5
Serological response to vaccination in post-acute sequelae of COVID.COVID 后急性后遗症患者的疫苗接种血清学反应。
BMC Infect Dis. 2023 Feb 16;23(1):97. doi: 10.1186/s12879-023-08060-y.
6
Occupational role and COVID-19 among foreign-born healthcare workers in Sweden: a registry-based study.在瑞典出生的医疗保健工作者的职业角色和 COVID-19:一项基于登记的研究。
Eur J Public Health. 2023 Apr 1;33(2):202-208. doi: 10.1093/eurpub/ckad016.
7
BIRCH: An Automated Workflow for Evaluation, Correction, and Visualization of Batch Effect in Bottom-Up Mass Spectrometry-Based Proteomics Data.BIRCH:一种用于 Bottom-Up 质谱蛋白质组学数据中批处理效应评估、校正和可视化的自动化工作流程。
J Proteome Res. 2023 Feb 3;22(2):471-481. doi: 10.1021/acs.jproteome.2c00671. Epub 2023 Jan 25.
8
Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020-2022.2020-2022 年智利两个城市人群队列中针对 SARS-CoV-2 病毒的天然和获得性免疫的血清流行率。
Viruses. 2023 Jan 10;15(1):201. doi: 10.3390/v15010201.
9
Sustained seropositivity up to 20.5 months after COVID-19.COVID-19 后长达 20.5 个月的持续血清阳性。
BMC Med. 2022 Oct 13;20(1):379. doi: 10.1186/s12916-022-02570-3.
10
In-hospital outcomes of SARS-CoV-2-infected health care workers in the COVID-19 pandemic first wave, Quebec, Canada.在 COVID-19 大流行第一波期间,加拿大魁北克省感染 SARS-CoV-2 的医护人员的院内转归。
PLoS One. 2022 Aug 24;17(8):e0272953. doi: 10.1371/journal.pone.0272953. eCollection 2022.
一项横断面研究调查大学生人群中严重急性呼吸综合征冠状病毒 2 抗体的血清阳性率。
J Adolesc Health. 2020 Dec;67(6):763-768. doi: 10.1016/j.jadohealth.2020.09.001. Epub 2020 Oct 15.
4
COVID-19 and the Path to Immunity.新冠病毒肺炎与免疫之路
JAMA. 2020 Oct 6;324(13):1279-1281. doi: 10.1001/jama.2020.16656.
5
Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area.纽约地区医护人员中 SARS-CoV-2 抗体的流行情况。
JAMA. 2020 Sep 1;324(9):893-895. doi: 10.1001/jama.2020.14765.
6
Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample - Indiana, April 25-29, 2020.基于全州随机样本的 SARS-CoV-2 感染人群现患率——印第安纳州,2020 年 4 月 25 日-29 日。
MMWR Morb Mortal Wkly Rep. 2020 Jul 24;69(29):960-964. doi: 10.15585/mmwr.mm6929e1.
7
The Structural and Social Determinants of the Racial/Ethnic Disparities in the U.S. COVID-19 Pandemic. What's Our Role?美国新冠疫情中种族/族裔差异的结构和社会决定因素。我们的角色是什么?
Am J Respir Crit Care Med. 2020 Oct 1;202(7):943-949. doi: 10.1164/rccm.202005-1523PP.
8
Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.急性呼吸窘迫综合征的 COVID-19 患者中 SARS-CoV-2 特异性 T 细胞的表型和动力学。
Sci Immunol. 2020 Jun 26;5(48). doi: 10.1126/sciimmunol.abd2071.
9
Review of Current Advances in Serologic Testing for COVID-19.新型冠状病毒血清学检测的研究进展综述
Am J Clin Pathol. 2020 Aug 5;154(3):293-304. doi: 10.1093/ajcp/aqaa112.
10
The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States.美国新冠疫情对少数族裔的不成比例影响。
Clin Infect Dis. 2021 Feb 16;72(4):703-706. doi: 10.1093/cid/ciaa815.